Andrew J. Last sold $990k of BIO
EVP, Chief Operating Officer at BIO-RAD LABORATORIES, INC.. 3,000 shares at an average of $329.94, traded Sep 6, 2024, filed Sep 10, 2024.
Score components
- +20RoleCOO
- +25Trade size$990k at market
- +10Share of holdings soldSold 28% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +2.8%, 3m +4.8%, 6m -22.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-24-016386, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 6, 2024 | MOption exercise Bio-Rad A Common Stock | +3,000 | $299.24 | $898k | 10,559 | Sep 10, 2024 |
| Sep 6, 2024 | SOpen-market sale Bio-Rad A Common Stock | -3,000 | $329.94 | $990k | 7,559 | Sep 10, 2024 |
| Sep 6, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -3,000 | $0.00 | $0 | 0 | Sep 10, 2024 |
Related signals
Other insiders at BIO-RAD LABORATORIES, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | BIOsell BIO-RAD LABORATORIES, INC. | Eva Anette Engelhardt EVP, President, CDG | $136k 550 shares | -61% | |
| 47Moderate | BIOsell BIO-RAD LABORATORIES, INC. | James Barry EVP, President, LSG | $214k 700 shares | -58% | |
| 31Weak | BIOsell BIO-RAD LABORATORIES, INC. | Michael Crowley EVP, GBL Commercial Operations | $741k 3,000 shares | -27% | |
| 40Moderate | BIO-RAD LABORATORIES, INC. | James Barry EVP, President, LSG | $206k 623 shares | -81% | |
| 25Weak | BIOsell BIO-RAD LABORATORIES, INC. | Michael Crowley EVP, GBL Commercial Operations | $104k 369 shares | -5% | |
| 28Weak | BIOsell BIO-RAD LABORATORIES, INC. | Steven D Schwartz owner | $148k 320 shares | -18% | |
| 41Moderate | BIO-RAD LABORATORIES, INC. | Timothy S Ernst EVP, General Counsel & Sec | $826k 2,500 shares | -42% | |
| 43Moderate | BIO-RAD LABORATORIES, INC. | Michael Crowley EVP, GBL Commercial Operations | $1.0M 3,000 shares | -30% | |
| 48Moderate | BIO-RAD LABORATORIES, INC. | Dara Wright EVP, President, CDG | $359k 1,200 shares | -44% | |
| 35Weak | BIO-RAD LABORATORIES, INC. | Michael Crowley EVP, GBL Commercial Operations | $196k 642 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.